Morgan Stanley Maintains Overweight on Danaher, Raises Price Target to $240
10/13/2026
Impact: 75
Healthcare
Morgan Stanley analyst Kallum Titchmarsh has maintained an Overweight rating on Danaher (NYSE: DHR) and raised the price target from $220 to $240. This adjustment reflects a positive outlook on the company's performance.
AI summary, not financial advice
Share: